Ergothioneine attenuates varicocele‐induced testicular damage by upregulating HSP90AA1 in rats

Qi Chen,Ranran Zhou,Cheng Yang,Qijun Jiang,Haoyu Yuan,Xin Qiu,Hu Tian,Junhao Zhou,Cundong Liu
DOI: https://doi.org/10.1002/jbt.23301
IF: 3.568
2023-01-18
Journal of Biochemical and Molecular Toxicology
Abstract:This study investigates the therapeutic effect and the underlying mechanisms of ergothioneine (EGT) on the testicular damage caused by varicocele (VC) in vivo, in vitro, and in silico. This preclinical study combines a series of biological experiments and network pharmacology analyses. A total of 18 Sprague Dawley (SD) male rats were randomly and averagely divided into three groups: the sham‐operated, VC model, and VC model with EGT treatment (VC + EGT) groups. The left renal vein of the VC model and the VC + EGT groups were half‐ligated for 4 weeks. Meanwhile, the VC + EGT group was intragastrically administrated with EGT (10 mg/kg). GC1 and GC2 cells were exposed to H2O2 with or without EGT treatment to re‐verify the conclusion. The structure disorder of seminiferous tubules ameliorated the apoptosis decrease in the VC rats receiving EGT. EGT can also increase the sperm quality of the VC model rats (p
biochemistry & molecular biology,toxicology
What problem does this paper attempt to address?